Cargando…
Intrinsic RIG-I restrains STAT5 activation to modulate antitumor activity of CD8(+) T cells
Antitumor activity of CD8(+) T cells is potentially restrained by a variety of negative regulatory pathways that are triggered in the tumor microenvironment, yet, the exact mechanisms remain incompletely defined. Here, we report that intrinsic RIG-I in CD8(+) T cells represents such a factor, as evi...
Autores principales: | Jiang, Xinyi, Lin, Jian, Shangguan, Chengfang, Wang, Xiaoyao, Xiang, Bin, Chen, Juan, Guo, Hezhou, Zhang, Wu, Zhang, Jun, Shi, Yan, Zhu, Jiang, Yang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145944/ https://www.ncbi.nlm.nih.gov/pubmed/36927693 http://dx.doi.org/10.1172/JCI160790 |
Ejemplares similares
-
RIG-I activation induces the release of extracellular vesicles with antitumor activity
por: Daßler-Plenker, Juliane, et al.
Publicado: (2016) -
Tumor suppressor activity of RIG-I
por: Li, Xian-Yang, et al.
Publicado: (2014) -
Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
por: Bek, Sarah, et al.
Publicado: (2019) -
CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity
por: Briceño, Pedro, et al.
Publicado: (2021) -
Intrinsic PD‐L1 promotes antitumor activity of CD8(+) cytotoxic T lymphocytes via in cis interaction with CD80
por: Ding, Yuming, et al.
Publicado: (2022)